Click for best price
TNF Inhibitors Market Size, Share 2023
| Market size in 2022 |
US$ 43420 million
|
Forecast Market size by 2029 |
US$ 46850 million
|
| Growth Rate |
CAGR of 1.1% |
Number of Pages |
61 Pages |
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflammation-causing substance. TNF inhibitor drugs are employed to treat inflammatory conditions such as rheumatoid arthritis and juvenile arthritis. Generally, in the healthy person, the TNF levels remain steady. However, in a patient with rheumatoid arthritis, the level of TNF is increasing which leads to more inflammation. TNF inhibitor drugs act as blockers for TNF substances. TNF alpha blockers are highly effective in the treatment of patients with active rheumatoid arthritis. These drugs are used in patients as a conventional second-line treatments.
This report aims to provide a comprehensive presentation of the global market for TNF Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TNF Inhibitors. This report contains market size and forecasts of TNF Inhibitors in global, including the following market information:
Global TNF Inhibitors Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global TNF Inhibitors market was valued at US$ 43420 million in 2022 and is projected to reach US$ 46850 million by 2029, at a CAGR of 1.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The adalimumab segment is likely to expand at a significant pace during the forecast period. The drug is effectively used in a broad range of pain management therapies and is widely available over the counter. Based on distribution channel, the TNF inhibitors market can be segmented into hospital pharmacy and retail pharmacy. The hospital pharmacy segment is likely to expand at a significant pace between 2017 and 2025, this is because patients with rheumatoid arthritis, arthritis give more preference to the hospitals for treatment. Increase in elderly population and rise in the prevalence of rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease are some of the factors that drive the TNF inhibitors market. According to the National Health Interview Survey, in 2016, almost 20% of the global population was reported to be suffering from chronic pain, with rheumatoid arthritis being one of the major reasons. Moreover, according to the Center for Disease Control and Prevention, by 2040, approximately 78 million (26%) of the U.S. adults are projected to have arthritis. Owing to this, the consumption of TNF inhibitor dugs is likely to increase rapidly in the near future. However, side-effects associated with the use of TNF inhibitor drugs such as skin irritation, flushing, headache, and abdominal pain are estimated to hinder the market in the next few years.
We surveyed the TNF Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global TNF Inhibitors Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global TNF Inhibitors Market Segment Percentages, by Type, 2022 (%)
Monotherapy
Combination Therapy
Global TNF Inhibitors Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global TNF Inhibitors Market Segment Percentages, by Application, 2022 (%)
Skin Disease
Ankylosing Spondylitis
Gastrointestinal Disease
Rheumatoid Arthritis
Others
Global TNF Inhibitors Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global TNF Inhibitors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies TNF Inhibitors revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies TNF Inhibitors revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Boehringer Ingelheim
Amgen
BioPharma
Mochida Pharmaceutical
Hanall
Outline of Major Chapters:
Chapter 1: Introduces the definition of TNF Inhibitors, market overview.
Chapter 2: Global TNF Inhibitors market size in revenue.
Chapter 3: Detailed analysis of TNF Inhibitors company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of TNF Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
TNF Inhibitors Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 43420 million
|
| Forecast Market size by 2029 |
US$ 46850 million
|
| Growth Rate |
CAGR of 1.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 TNF Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global TNF Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global TNF Inhibitors Overall Market Size
2.1 Global TNF Inhibitors Market Size: 2022 VS 2029
2.2 Global TNF Inhibitors Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top TNF Inhibitors Players in Global Market
3.2 Top Global TNF Inhibitors Companies Ranked by Revenue
3.3 Global TNF Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 TNF Inhibitors Companies in Global Market, by Revenue in 2022
3.5 Global Companies TNF Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 TNF Inhibitors Players in Global Market
3.6.1 List of Global Tier 1 TNF Inhibitors Companies
3.6.2 List of Global Tier 2 and Tier 3 TNF Inhibitors Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global TNF Inhibitors Market Size Markets, 2022 & 2029
4.1.2 Monotherapy
4.1.3 Combination Therapy
4.2 By Type - Global TNF Inhibitors Revenue & Forecasts
4.2.1 By Type - Global TNF Inhibitors Revenue, 2018-2023
4.2.2 By Type - Global TNF Inhibitors Revenue, 2024-2029
4.2.3 By Type - Global TNF Inhibitors Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global TNF Inhibitors Market Size, 2022 & 2029
5.1.2 Skin Disease
5.1.3 Ankylosing Spondylitis
5.1.4 Gastrointestinal Disease
5.1.5 Rheumatoid Arthritis
5.1.6 Others
5.2 By Application - Global TNF Inhibitors Revenue & Forecasts
5.2.1 By Application - Global TNF Inhibitors Revenue, 2018-2023
5.2.2 By Application - Global TNF Inhibitors Revenue, 2024-2029
5.2.3 By Application - Global TNF Inhibitors Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global TNF Inhibitors Market Size, 2022 & 2029
6.2 By Region - Global TNF Inhibitors Revenue & Forecasts
6.2.1 By Region - Global TNF Inhibitors Revenue, 2018-2023
6.2.2 By Region - Global TNF Inhibitors Revenue, 2024-2029
6.2.3 By Region - Global TNF Inhibitors Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America TNF Inhibitors Revenue, 2018-2029
6.3.2 US TNF Inhibitors Market Size, 2018-2029
6.3.3 Canada TNF Inhibitors Market Size, 2018-2029
6.3.4 Mexico TNF Inhibitors Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe TNF Inhibitors Revenue, 2018-2029
6.4.2 Germany TNF Inhibitors Market Size, 2018-2029
6.4.3 France TNF Inhibitors Market Size, 2018-2029
6.4.4 U.K. TNF Inhibitors Market Size, 2018-2029
6.4.5 Italy TNF Inhibitors Market Size, 2018-2029
6.4.6 Russia TNF Inhibitors Market Size, 2018-2029
6.4.7 Nordic Countries TNF Inhibitors Market Size, 2018-2029
6.4.8 Benelux TNF Inhibitors Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia TNF Inhibitors Revenue, 2018-2029
6.5.2 China TNF Inhibitors Market Size, 2018-2029
6.5.3 Japan TNF Inhibitors Market Size, 2018-2029
6.5.4 South Korea TNF Inhibitors Market Size, 2018-2029
6.5.5 Southeast Asia TNF Inhibitors Market Size, 2018-2029
6.5.6 India TNF Inhibitors Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America TNF Inhibitors Revenue, 2018-2029
6.6.2 Brazil TNF Inhibitors Market Size, 2018-2029
6.6.3 Argentina TNF Inhibitors Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa TNF Inhibitors Revenue, 2018-2029
6.7.2 Turkey TNF Inhibitors Market Size, 2018-2029
6.7.3 Israel TNF Inhibitors Market Size, 2018-2029
6.7.4 Saudi Arabia TNF Inhibitors Market Size, 2018-2029
6.7.5 UAE TNF Inhibitors Market Size, 2018-2029
7 TNF Inhibitors Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer TNF Inhibitors Major Product Offerings
7.1.4 Pfizer TNF Inhibitors Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis TNF Inhibitors Major Product Offerings
7.2.4 Novartis TNF Inhibitors Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim TNF Inhibitors Major Product Offerings
7.3.4 Boehringer Ingelheim TNF Inhibitors Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen TNF Inhibitors Major Product Offerings
7.4.4 Amgen TNF Inhibitors Revenue in Global Market (2018-2023)
7.4.5 Amgen Key News & Latest Developments
7.5 BioPharma
7.5.1 BioPharma Company Summary
7.5.2 BioPharma Business Overview
7.5.3 BioPharma TNF Inhibitors Major Product Offerings
7.5.4 BioPharma TNF Inhibitors Revenue in Global Market (2018-2023)
7.5.5 BioPharma Key News & Latest Developments
7.6 Mochida Pharmaceutical
7.6.1 Mochida Pharmaceutical Company Summary
7.6.2 Mochida Pharmaceutical Business Overview
7.6.3 Mochida Pharmaceutical TNF Inhibitors Major Product Offerings
7.6.4 Mochida Pharmaceutical TNF Inhibitors Revenue in Global Market (2018-2023)
7.6.5 Mochida Pharmaceutical Key News & Latest Developments
7.7 Hanall
7.7.1 Hanall Company Summary
7.7.2 Hanall Business Overview
7.7.3 Hanall TNF Inhibitors Major Product Offerings
7.7.4 Hanall TNF Inhibitors Revenue in Global Market (2018-2023)
7.7.5 Hanall Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. TNF Inhibitors Market Opportunities & Trends in Global Market
Table 2. TNF Inhibitors Market Drivers in Global Market
Table 3. TNF Inhibitors Market Restraints in Global Market
Table 4. Key Players of TNF Inhibitors in Global Market
Table 5. Top TNF Inhibitors Players in Global Market, Ranking by Revenue (2022)
Table 6. Global TNF Inhibitors Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global TNF Inhibitors Revenue Share by Companies, 2018-2023
Table 8. Global Companies TNF Inhibitors Product Type
Table 9. List of Global Tier 1 TNF Inhibitors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 TNF Inhibitors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global TNF Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - TNF Inhibitors Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - TNF Inhibitors Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global TNF Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - TNF Inhibitors Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - TNF Inhibitors Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global TNF Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global TNF Inhibitors Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global TNF Inhibitors Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America TNF Inhibitors Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America TNF Inhibitors Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe TNF Inhibitors Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe TNF Inhibitors Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia TNF Inhibitors Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia TNF Inhibitors Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America TNF Inhibitors Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America TNF Inhibitors Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa TNF Inhibitors Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa TNF Inhibitors Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer TNF Inhibitors Product Offerings
Table 32. Pfizer TNF Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis TNF Inhibitors Product Offerings
Table 36. Novartis TNF Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Boehringer Ingelheim Company Summary
Table 39. Boehringer Ingelheim TNF Inhibitors Product Offerings
Table 40. Boehringer Ingelheim TNF Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 41. Boehringer Ingelheim Key News & Latest Developments
Table 42. Amgen Company Summary
Table 43. Amgen TNF Inhibitors Product Offerings
Table 44. Amgen TNF Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 45. Amgen Key News & Latest Developments
Table 46. BioPharma Company Summary
Table 47. BioPharma TNF Inhibitors Product Offerings
Table 48. BioPharma TNF Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 49. BioPharma Key News & Latest Developments
Table 50. Mochida Pharmaceutical Company Summary
Table 51. Mochida Pharmaceutical TNF Inhibitors Product Offerings
Table 52. Mochida Pharmaceutical TNF Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 53. Mochida Pharmaceutical Key News & Latest Developments
Table 54. Hanall Company Summary
Table 55. Hanall TNF Inhibitors Product Offerings
Table 56. Hanall TNF Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 57. Hanall Key News & Latest Developments
List of Figures
Figure 1. TNF Inhibitors Segment by Type in 2022
Figure 2. TNF Inhibitors Segment by Application in 2022
Figure 3. Global TNF Inhibitors Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global TNF Inhibitors Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global TNF Inhibitors Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by TNF Inhibitors Revenue in 2022
Figure 8. By Type - Global TNF Inhibitors Revenue Market Share, 2018-2029
Figure 9. By Application - Global TNF Inhibitors Revenue Market Share, 2018-2029
Figure 10. By Type - Global TNF Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global TNF Inhibitors Revenue Market Share, 2018-2029
Figure 12. By Application - Global TNF Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global TNF Inhibitors Revenue Market Share, 2018-2029
Figure 14. By Region - Global TNF Inhibitors Revenue Market Share, 2018-2029
Figure 15. By Country - North America TNF Inhibitors Revenue Market Share, 2018-2029
Figure 16. US TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 17. Canada TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe TNF Inhibitors Revenue Market Share, 2018-2029
Figure 20. Germany TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 21. France TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 23. Italy TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 24. Russia TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia TNF Inhibitors Revenue Market Share, 2018-2029
Figure 28. China TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 29. Japan TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 32. India TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America TNF Inhibitors Revenue Market Share, 2018-2029
Figure 34. Brazil TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa TNF Inhibitors Revenue Market Share, 2018-2029
Figure 37. Turkey TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 38. Israel TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 40. UAE TNF Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer TNF Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis TNF Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boehringer Ingelheim TNF Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Amgen TNF Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. BioPharma TNF Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Mochida Pharmaceutical TNF Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Hanall TNF Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
